Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients

Molecular and Cellular Biochemistry

Volumn 302, Issue 1-2, 2007, Pages 195-201

  Abdulle, Abdishakur M ^a   Gillett, Michael P T ^b   Abouchacra, Samra ^c   Sabri, Sufyan M ^a   Rukhaimi, Mona Al ^d   Obineche, Enyioma N ^a   Singh, Jaipaul ^e  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b Saba University   (Netherlands Antilles)

^c TAWAM HOSPITAL   (United Arab Emirates)

^d DUBAI HOSPITAL   (United Arab Emirates)

^e UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Blood pressure; Cardiovascular risk factors; Chronic kidney disease; IGF 1; Insulin like growth factor 1; United Arab Emirates

Indexed keywords

GROWTH HORMONE; INSULIN; LEPTIN; SOMATOMEDIN C;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; KIDNEY FAILURE; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RISK FACTORS;

EID: 34547632565     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9441-6     Document Type: Article

References (52)

1. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J (2002) Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13:S28-S36
2. de Mutsert R, Krediet RT (2006) Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients. Ned Tijdschr Geneeskd 150:2023-2027
3. Laron Z, Wang XL, Klinger B, Silbergeld A, Davidovits M, Eisentein Wilcken D (1996) Growth hormone treatment increase circulating lipoproteins in children with chronic renal failure. J Pediatr Endocrinol Metab 9:533-537
4. Owen WF, Madore F, Brenner BM (1996) An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors. Am J Kidney Dis 28:931-936
5. Goldsmith DJ, Covic AC, Venning MC, Ackrill P (1997) Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis 29:593-600
6. Kohlhagen J, Kelly J (2003) Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure. Nephrology 8:274-279
7. Covic A, Gusbeth-Tatomir P, Goldsmith D (2003) The challenge of cardiovascular risk factors in end stage renal disease. J Nephrol 16:476-486
8. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G (2004) The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10-year survey. Nephrol Dial Transplant 19:1829-1834
9. Ferns GA, Morani AS, Anggard EE (1991) The insulin-like growth factors: their putative role in atherosgenesis. Artery 18:197-225
10. Janssen JA, Stolk RP, Pols HA (1998) Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: Relation to age and sex steroid levels. Clin Endocrinol 48:471-478
11. Harrela M, Koistinen R, Tuomilehto J, Nissinen A, Seppala M (2000) Low serum insulin-like growth factor-binding protein-1 is associated with an unfavourable cardiovascular risk profile in elderly men. Ann Med 32:424-428
12. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T (2002) Low serum insulin-like growth factor-1 is associated with increased risk of ischemic heart disease: A population-based study case control. Circulation 106:939-944
13. Laughlin GA, Barret-Conner E, Criqui MH, Kritz-Silverstein D (2004) The prospective association of serum insulin-like growth factor-1 and IGF-binding protein-1 levels with all cause and cardiovcascular disease mortality in older adults: The rancho Bernardo Study. J Clin Endocrinol Metab 89:114-120
14. Laviades C, Gil MJ, Monreal I, Gonzalez A, Diez J (1997) Is the tissue availability of circulating insulin-like growth factor involved in orhgan damage and glucose regulation in hypertension? J Hypertension 15:1159-1165
15. Van den Brande JL, Hoogerbrugge CM, Beyreuther K, Roepstorff P, Jansen J, van Buul-Offers SC (1990) Isolation and partial characterization of IGF-like peptides from Cohn fraction IV of human plasma. Acta Endocrinol (Copenh) 122:683-695
16. Mathews LS, Norstedt G, Palmiter RD (1986) Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 83:9343-9347
17. Radosavljevic T, Todorovic V, Vucevic D, Sikic B (2005) The growth hormone axis and insulin-like growth factors. Med Pregl 58:558-562
18. Raile K, Klammt J, Schneider A, Keller A, Laue S, Smith R, Pfaffle R, Kratzsch J, Keller E, Kiess W (2006) Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor 1 receptor (IGF1R) mutation: Implications for a gene dosage effect of the human IGF1R. J Clin Endocrinol Metab doi:10.1210/jc
19. Szczech LA, Reddan DN, Klassen PS, Coladonato J, Chua B, Lowrie EG, Lazarus JM, Owen WF Jr (2003) Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients. Nephrol Dial Transplant 18:1585-1591
20. Fouque D, Juillard L, Lasne Y, Tabakian A, Laville M, Joly MO, Laville M (1998) Acute leptin regulation in end-stage renal failure: The role of growth hormone and IGF-1. Kidney Int 54:932-937
21. Rodriguez-Carmona A, Perez Fontan M, Cordido F, Garcia Falcon T, Garcia-Buela J (2000) Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure: A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 86:274-280
22. Rouche F, Westermann F, Englaro P, Blum WF, Schonau E (1998) Serum leptin is suppressed by growth hormone therapy in growth hormone-deficient children. Horm Res 50:18-21
23. Patel L, Webb NJ, Bradbury MG, Zaman N, Smith P, Lewis MA Postlethwaite RJ, Price DA, Clayton PE (2002) Serum leptin and IGF-I during growth hormone treatment in chronic renal failure. Pediatr Nephrol 17:643-647
24. Fervenza FC, Friedlaender MM, Ike JO, Rabkin R (1998) Insulin-like growth factor-I treatment to enhance renal function in advanced chronic renal failure. Ren Fail 20:349-356
25. Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H (1999) Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int 56:2076-2084
26. Obineche EN, Gillett PT, Abdulle AM, Sulaiman MN, Rokhaimi MA (2002) Leptin, lipid and lipid metabolism-related hormones in Chronic kidney disease in Arabia. Nephrology 7:115-120
27. Burkhard Tönshoff, Daniela Kiepe, Sonia Ciarmatori (2005) Growth hormone/insulin-like growth factor; system in children with chronic renal failure. Pediatr Nephrol 20:279-289
28. Haffner D, Blum W, Heinrich U, Mehls O, Tönshoff B (1997) Impaired Postprandial Regulation of Insulin-Like Growth Factor Binding Protein-1in Children with Chronic Renal Failure. J Clin Endocrinol Metab 82:2832-2835
29. Burch WM, Correa J, Shively JE, Powell DR (1990) The 25 kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-mediated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab 70:173-180
30. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC (1991) Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 129:2254-2256
31. Benbassat CA, Maki KC, Unterman TG (1997) Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in ageing men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 82:1484-1491
32. Powell DR, Suwanichkul A, Cubbage ML, DePaolis LA, Snuggs MB, Lee PD (1991) Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 266:18868-18876
33. Wheatcroft SB, Kearney MT, Shah AM, Grieve DJ, Williams IL, Miell JP, Crossey PA (2003) Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1. Diabetes 52:2075-2082
34. Watanabe T, Itokawa M, Nakagawa Y, Iguchi T, Katagiri T (2003) Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis. Am J Hypertens 16:754-760
35. Kurbanov RD, Eliseeva MR, Tursunov RR, Kurbanova DR, Zakirova FA (2003) Humoral markers of endothelial dysfunction in essential hypertension. Kardiologiia 43:61-64
36. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G (1994) Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 41:351-357
37. Holmes MD, Pollak MN, Hankinson SE (2002) Lifestyle Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations. Cancer Epidemiol Biomark Prev 11:862-867
38. Teramukai S, Rohan T, Eguchi H, Oda T, Shinchi K, Kono S (2002) Anthropometric and Behavioral Correlates of Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 in Middle-aged Japanese Men. Am J Epidemiol 156:344-348
39. Goodman-Gruen D, Barrett-Connor E (1997) Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145:970-976
40. Harris T, Kiel D, Roubenoff R, Langlois J, Hannan M, Havlik R (1997) Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: The Framingham Heart Study. J Am Geriatr Soc 45:133-139
41. Johanson AJ, Blizzard RM (1981) Low somatomedin-C levels in older men rise in response to growth hormone administration. Johns Hopkins Med J 149:115-117
42. Sonksen PH, Cuneo RC, Salomon F, McGauley G, Wiles CM, Wilmshurst P, Byrne C, Hesp R, Lowy C, Weissberger A (1991) Growth hormone therapy in adults with growth hormone deficiency. Acta Paediatr Scand 379:139-147
43. Tungtrongchitr R, Pongpaew P, Phonrat B, Tribunyatkul S, Viroonudomphol D, Supawan V, Jintaridhi P, Lertchavanakul A, Vudhivai N, Schelp FP (2001) Serum leptin and lipid profiles in Thai obese and overweight subjects. Int J Vit Nut Res 71:74-81
44. D'Costa AP, Ingram RL, Lenham JE, Sonntag WE (1993) The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing. J Reprod Fertil Suppl 46:87-98
45. Juul A, Bang P, Hertel NT (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78:744-752
46. O'Connor KG, Tobin JD, Harman SM (1998) Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol A Biol Sci Med Sci 53:176-182
47. Seck T, Scheidt-Nave C, Ziegler R (1998) Positive association between circulating free thyroxine and insulin-like growth factor l concentrations in euthyroid elderly individuals. Clin Endocrinol 48:361-366
48. Rutanen EM, Karkkainen T, Stenman UH, Yki-Jarvinen H (1993) Ageing is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J Clin Endocrinol Metab 77:1152-1155
49. Juul A (2003) Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13:113-170
50. Kocyigit Y, Bayhan G, Atamer A, Atamer Y (2004) Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 18:341-348
51. Adeyemi E, Abdulle A (2000) A comparison of plasma leptin levels in obese and lean individuals in the United Arab Emirates. Nutr Res 20:157-166
52. Ogier V, Ziegler O, Mejean L, Nicolas JP, Stricker-Krongrad A (2002) Obesity is associated with decreasing levels of the circulating soluble leptin receptor in humans. Int J Obes Relat Metab Disord 26:496-503